biocompatible collagen therapy burns

Biocompatible Collagen Therapy in Burns — Recovery with Topical Homologous Human Collagen

Biocompatible Collagen Therapy in Burns — Faster Recovery with Topical Homologous Human Collagen

The clinical rationale for recombinant collagen in post-burn skin recovery

Medically reviewed · Updated April 2026

The clinical principle

Burn recovery involves the same collagen remodelling biology as post-procedure recovery — but with greater urgency. Biocompatible, structurally homologous collagen supports this process from the first application.


REVAGI The Recombinant Serum delivers topical homologous human collagen — structurally identical to human Type I collagen — to support skin recovery after thermal and energy-based injury.

Why Burn Recovery Demands Biocompatible Collagen

Thermal injury disrupts the skin barrier, destroys collagen architecture in the dermis, and triggers an intense inflammatory and repair response. The quality of the collagen rebuilt during the proliferation and remodelling phases determines the long-term outcome — skin texture, scar quality, and pigmentation.

biocompatible collagen therapy burns diagram

Animal-derived collagen products carry immunogenic risk — significant on a compromised barrier where absorption is dramatically elevated. Structurally homologous recombinant collagen is recognised by human tissue as self — no immunogenic response, no risk of rejection.

Ferreira AM et al., Acta Biomater. 2012. Pharmaceuticals. 2023. — Recombinant human collagen purity and regenerative properties.


The Three Mechanisms That Matter in Burn Recovery

  • Biomimetic surface layer — structurally resembles the damaged ECM; provides a scaffold-like signal for fibroblast activity and new tissue organisation
  • Anti-inflammatory modulation — moderates the intense inflammatory response characteristic of burn injury; supports more efficient progression to the proliferation phase
  • Fibroblast regulation — guides collagen synthesis toward organised Type I formation; reduces risk of hypertrophic scarring from excessive fibroblast activity

Liu TS et al., Regen Biomater. 2024. Advances in Wound Care. 2025.

REVAGI The Recombinant Serum is a cosmetic skincare product — not a medical device or wound treatment. For acute burn management, always seek immediate medical care from a qualified healthcare provider. No therapeutic claims are made.

Post-Burn Skin Recovery — Supporting the Remodelling Phase

Once the acute wound phase has been managed medically and the skin surface has closed, the remodelling phase begins. This is where topical recombinant collagen has its most significant cosmetic role — supporting the quality and organisation of the new collagen being synthesised.

The same principles apply after energy-based aesthetic treatments: CO2 laser, pico laser, and RF microneedling all involve controlled thermal or mechanical injury that triggers the same repair cascade. See the full biology: the role of collagen in post-procedure recovery and topical homologous human collagen in recovery.

Post-procedure skin recovery

REVAGI The Recombinant Serum

Topical homologous human collagen · SCIRA™ technology · licensed clinics

No retinoids · No AHAs/BHAs · No fragrance · Cosmetic serum

Back to blog